The global pet diabetes care devices market is witnessing substantial growth, with a current valuation of USD 2.3 billion in 2023 and a projected rise to USD 4.3 billion by 2033. This growth trajectory is driven by a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Veterinary clinics are playing a crucial role in propelling the global pet diabetes care devices market forward. Healthcare professionals and animal caretakers in these clinics are increasingly recommending and utilizing pet diabetes care devices to enhance pet health management. These advanced devices are essential for detecting, monitoring, and managing common health issues in pets, thereby preventing potential complications and ensuring better overall pet care.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-14346
The increased awareness and proactive approach by veterinary clinics towards pet health are significantly contributing to the adoption of diabetes care devices. By leveraging these devices, pet owners can effectively manage their pets’ health, leading to improved quality of life for their beloved companions.
Pet diabetes care devices include insulin pens, glucose monitoring systems, and glucose meters. These pet diabetes are designed with different sizes and shapes and add an advanced feature to access easily. Veterinary clinics inform pet owners about pet conditions and guide them about the devices and their benefits. They educate pet owners to provide better nutritious food and monitor blood glucose.
Veterinary clinics provide pet diabetes care devices to their clients to monitor their pets regularly at home. They also provide training on the uses of these devices with comprehensive care. Pets diagnosed with diabetes are continuously rising, and are surging the demand for pet diabetes care devices. Veterinary clinics play a key role in expanding the market by offering pet owners a better tool to support their pets’ health conditions.
Key Takeaways:
- The pet diabetes care devices market is registering a CAGR of 6.2% with a valuation of USD 4.3 billion by 2033.
- In the historical period, the market captured a CAGR of 5.7%, with a valuation of USD 1.7 billion in 2018.
- The United States is a prominent leader in the global market, registering a share of 27% during the forecast period.
- China is one of the significant countries in the Asia Pacific that securing a CAGR of 8.20% by 2033.
- During the forecast period, India is registering a CAGR of 7.50% in the global market.
Customization Available Request: https://www.futuremarketinsights.com/customization-available/rep-gb-14346
How Key Players are Focus on Adding Values in the Global Market?
Key players are focusing on innovating pet diabetes care devices by adding advanced features resulting in accuracy, convenience, and ease to use. The key players are deploying small sensors in these devices to monitor pets’ health conditions, such as blood glucose levels. These devices work on a real-time basis as pet owners track the condition of their pets and provide them with healthy nutrition with a proper dietary plan.
The key players developing specially design insulin syringes to provide more accurate information than other devices. These devices provide quick results, increasing the adoption of pet healthcare to treat pets’ poor health conditions. Conversely, guiding pet owners, growing awareness, and innovating easy-to-access pet care devices improve pet health.
Recent Developments in the Global Pet Diabetes Care Devices Market are:
- In September 2021, Zoetis Inc launched its new product VETSCAN IMAGYST. This device offers to monitor pets’ diabetes and health conditions.
- In July 2021, Merck Animal Health launched Vetsulin to manage pets’ diabetes.
- In 2020, IDEXX Laboratories announced its new product device IDEXX SDMA Test to identify kidney disease in cats and dogs and also the complication of diabetes.
- In 2019, Vetoquinol announced its acquisition with Epitopix to provide vaccination for diabetes-diagnosed pets.
Other Essential Players in the Global Market are:
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
Get a Full Report: https://www.futuremarketinsights.com/checkout/14346
Pet Diabetes Care Devices Market by Category:
By Animal Type:
- Cats
- Dogs
- Horses
By Device:
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
By End User:
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
